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Exercise Therapy and the Additional Effect of Supervision on Exercise
Therapy in Patients with Intermittent Claudication. Systematic Review
of Randomised Controlled Trials
J. Wind* and M.J.W. Koelemay
Tergooiziekenhuizen, location Hilversum, Department of Surgery, The Netherlands
Objective. To review the evidence for the effectiveness of exercise therapy and to estimate the additional effect of super-
vision on exercise therapy in patients with intermittent claudication.
Materials and methods. A systematic review was performed of all randomised controlled trials (RCTs) comparing
supervised exercise therapy to unsupervised exercise regimens or observation in patients with intermittent claudication.
Main endpoints were pain free walking distance (PWD) and absolute walking distance (AWD). Quality assessment
and data extraction were performed independently by two observers.
Results. Fifteen manuscripts, published between 1990 and May 2006, were eligible for analysis, evaluating 761 patients.
In the studies comparing supervised exercise to standard care the weighted mean difference in pain free walking distance
(PWD) and absolute walking distance (AWD) was 81.3 meters (95% CI; 35.5e127.1) and 155.8 meters (95% CI; 80.8e
230.7), respectively. In the studies comparing supervised to unsupervised exercise therapy, the weighted mean difference in
PWD and AWD was 143.8 meters (95% CI; 5.8e281.8) and 250.4 meters (95% CI; 192.4-308.5).
Conclusion. Exercise therapy increases the PWD and AWD in patients with intermittent claudication. Supervised exer-
cise therapy increases the PWD and AWD more than standard care. However, the additional value of supervision over
unsupervised exercise regimens needs further clarification.
Keywords: Claudication; Exercise; Supervision; Peripheral vascular disease; Meta-analysis.Introduction
Intermittent claudication is a life-style limiting mani-
festation of peripheral arterial occlusive disease. The
age-adjusted prevalence is approximately 12 percent
and increases to 20 percent if only patients older
than 70 years are considered.1 Current treatment is
aimed at risk factor modification, improvement of
quality of life by relieving symptoms, or more inva-
sive approaches such as angioplasty or surgery. The
choice for one or more of the above mentioned modal-
ities depends on the localisation and extent of the vas-
cular lesion(s), and the patient’s co-morbidity and
preferences.
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ment compared to radiological or surgical interven-
tions. Several mechanisms for the reported benefits
of (supervised) exercise therapy have been proposed.
These mechanisms include increased collateral blood
flow and redistribution, changes in microcirculation
and endothelial function, improved oxidative meta-
bolism and oxygen extraction, beneficial influences
on haemo-rheological factors, improved walking
economy, conditioning and favourable effects on risk
factors.1
Several exercise regimes have been investigated, all
including short periods of walking or other forms of
exercise inducing discomfort or pain, interspersed
with short periods of rest. These cycles are performed
up to one hour and repeated three to five times per
week. Exercise therapy can be performed by patients
individually after an instruction session, or under
supervision. The addition of supervision is proposedrved.
2 J. Wind and M. J. W. Koelemayto have a favourable effect on walking distance as
compared to unsupervised exercise therapy.
Ina systematic reviewofuncontrolled cohort studies,
Gardner et al. found that supervised exercise therapy
improved the pain free and maximum walking time
with 180% and 120%, respectively.2 They concluded
that exercise therapy should comprise intermittent
walking to near maximal pain for at least 30 minutes
with a minimum of three sessions per week, for at least
6 months. A Cochrane review including randomised
and clinical controlled trials comparing supervised ex-
ercise therapy to non-supervised exercise therapy
found an improvement in walking ability of approxi-
mately 150 meters.3 Since then, more randomised trials
evaluating supervised exercise versus non supervised
exercise or standard care have been published. How-
ever, despite all available data, uncertainty remains as
to whether supervised exercise therapy has additional
value over unsupervised regimens, and also about the
optimal intensity andduration of exercise programmes.
The aim of this systematic review was to assess the
effects of exercise therapy compared to standard care
on pain free and absolute walking distance in patients
with intermitted claudication due to peripheral arte-
rial occlusive disease. Secondly, the additional benefit
of supervision during exercise therapy was evaluated.
Materials and Methods
Literature search
The Cochrane Database of systematic reviews, the
Cochrane central register of controlled trials, the ACP
journal club, the database of abstracts of reviews of
effects (DARE), Medline, and Embase databases
were searched by using the MESH headings and key-
words ‘‘claudication’’, ‘‘intermittent claudication’’,
‘‘exercise’’, ‘‘exercise therapy’’ and ‘‘randomized OR
randomised’’ to identify randomised trials published
between 1966 and May 2006. Two investigators (MK,
JW) independently performed the literature search.
Electronic links to related articles and references of
selected articles were hand-searched as well. Leading
investigators in the field were contacted to inquire
whether studies were missed or publications were
recently submitted. A hand search of relevant journals
and conference proceedings was not performed. We
did not use a language restriction.
Study selection and data extraction
From the potentially eligible studies only randomised
trials were included comparing supervised exerciseEur J Vasc Endovasc Surg Vol 34, July 2007therapy and unsupervised exercise regimens, or ob-
servation in patients with intermittent claudication
from peripheral arterial occlusive disease. Studies
were included if they presented data as pain free walk-
ing distance (PWD) and/or absolute walking distance
(AWD) expressed in meters and the standard devia-
tion, or if these data could be derived from the original
paper. The same investigators independently ex-
tracted data from the trials including age, proportion
of male subjects, other treatment apart from
intervention, (supervised) exercise regimen, control
regimen, duration of intervention, complications re-
lated to exercise, and drop-out rate. If necessary data
could not be abstracted from the original publications,
corresponding authors were contacted and asked to
provide these data. Duplicate publications were ex-
cluded. If papers repeatedly reported on (parts of)
the same study population, only the first publication
was included. Each of the selected trials was critically
appraised by the two investigators, using a critical re-
view checklist for study validity as proposed by the
Dutch Cochrane Collaboration.4 Data were extracted
from original publications only. Final inclusion was
done after consensus was reached. Discrepancies in
judgement, if any, were resolved by discussion.
Analysis and presentation of data
The PWD and AWD were expressed as meters stan-
dard deviation (SD). In case the PWD and AWD were
reported as times, these were transformed to meters
SD with the help of the reported walking speed, how-
ever irrespective of the slope of the treadmill. Quanti-
tative data were entered into the Cochrane Review
Manager 4.2 software and analysed using RevMan
Analyses 1.0.2 (The Cochrane Collaboration, Oxford,
UK).5 Statistical heterogeneity was tested using Chi-
square and I-square statistics. Data were pooled using
a fixed effects model if heterogeneity was limited, the
random effects model was used when heterogeneity
was apparent. Summary estimates of treatment
effects, including 95% confidence intervals (CI), were
calculated for each comparison. For the continuous
outcome data, i.e. PWD and AWD, means and SD
were used to calculate a weighted mean difference
(WMD) in the meta-analysis.
Results
Included studies
The searches identified 8 systematic reviews that were
used for retrieving additional studies.2,3,6e11 The
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Fourteen of these 28 publications were excluded;
two controlled clinical trials without random treat-
ment allocation12,13; one study comparing two super-
vised regimes with different intensity14; 3 studies
were excluded because either part or all of the data
had been used in other publications,15e17 and 8 stud-
ies were excluded because of insufficient details or
unclear reporting.18e25 In four of these studies the
reason for exclusion was that the SD of the mean
PWD and AWD was not reported. Fortunately, two
authors of other studies provided such data on
request.26,27 One additional study was identified after
personal communication.28 Our definitive analysis
comprised 15 studies that were published between
1990 and 2006 and reported on a total of 761 ran-
domised patients, with a range of 14 to 149 patients
per study.26e41
Table 1 lists the study design, while in Table 2 the
quality assessment of the included studies is pre-
sented. The included studies had several limitations.
There were only small single-centred studies and
although all studies were randomised controlled
trials, only few provided details about the process of
randomisation. Attempts to minimise bias by conceal-
ment of allocation,27 or blinding of the assessor to the
allocated treatment when patients underwent their
final testing38 were sparse. Nearly half of the manu-
scripts reported that the results were analysed on an
intention to treat basis.
Exercise- and control regimens
Ten studies compared supervised exercise therapy
with standard care (observation and/or medication).
The control-patients in the other 5 studies received
unsupervised exercise therapy, in general consisting
of instructions only (Table 3). Most of the supervised
exercise regimens lasted 12-26 weeks with a frequency
of 2 to 3 times per week. In the study by Jansen et al.
the supervised exercise regime lasted 2 years.41 Drop-
out rates, after randomisation ranged between the
0 and 50%. Most of the drop-outs were related to
medical reasons or refusal by the patient to continue
in the programme. Similar drop-out rates were re-
ported in the control groups, also related to medical
reasons or patient refusal. Few patients participating
in the trials experienced adverse effects. Only one
study reported an 8% complication rate consisting
of minor leg injury.27 In the other studies complica-
tion rates were not reported or there were no
complications.Pain free- (PWD) and absolute walking distance (AWD)
Table 4 lists the PWD and AWD on entry and after the
intervention. In the studies comparing supervised
exercise therapy versus standard care change in
PWD and AWD ranged from 32 to 230 meters and
from 11 to 306 meters, respectively in the supervised
exercise group and from 38 to 40 meters and from
19 to 74 meters, respectively in the control group.
In the studies comparing supervised versus unsuper-
vised exercise therapy the change in PWD and AWD
ranged from 32 to 339 meters and from 184 to 491
meters respectively in the supervised exercise group
and from 2 to 99 meters and from 5 to 205 meters
respectively in the control group.
Although there was evidence of clinical and statis-
tical heterogeneity we decided to pool the individual
study results because all effects of the intervention
were in the same direction. Fig. 1 shows the results
for the effect of exercise therapy on PWD. In the 8 stud-
ies that compared supervised exercise to standard care
the WMD in PWD was 81.29 meters (95% CI; 35.45-
127.14) in favour of exercise therapy. In the 4 studies
comparing supervised to unsupervised exercise ther-
apy the WMD in PWD was 143.81 meters (95% CI;
5.81-281.81) in favour of the supervised regimen. The
WMD of all 12 studies comprising 522 patients (super-
vised exercise versus unsupervised or standard care)
was 94.65 meters (95% CI; 54.78e134.52).
Fig. 2 shows the results for the effect of exercise
therapy on AWD. In the 9 studies that compared su-
pervised exercise to standard care, the WMD in
AWD was 155.79 meters (95% CI; 80.84-230.74). In
the 5 studies comparing supervised to unsupervised
exercise therapy the WMD in AWD was 250.40 meters
(95% CI; 192.35-308.45). The WMD of all the 14 studies
comprising 626 patients (supervised exercise versus
unsupervised or standard care) was 171.75 meters
(95% CI; 106.70-236.81).
Discussion
The objective of this review was to assess the evidence
of exercise therapy and to estimate the additional ef-
fect of supervision on exercise therapy in patients
with intermittent claudication, to provide high level
evidence that may help future health care planning.
Many vascular surgeons do not have access to a reha-
bilitation centre for carrying out supervised exercise
therapy. The results of our study could influence daily
practice as it might be that the choice between super-
vised or unsupervised exercise therapy mainly isEur J Vasc Endovasc Surg Vol 34, July 2007
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Study N *
Randomized
Int vs Cont
Inclusion Exclusion Medication
Mika38 49 vs 49 50e70 years old, fontaine II
ABIrest< 0.9, ABIex< 0.75
PWD 50e200 meters, 3 mhs
stable
Vascular surgery <1 year,
cardiac or pulmonary
impairment, diabetes,
cancer, kidney or liver disease,
arthritis limiting exercise,
cardiac infarction within 6 mhs,
Beta-blocking or Pentoxifylline
Continued
Kakkos27 12 vs 9 Occlusion a femoralis
com >6 cm
6 mhs stable, ABIrest< 0.9
AWD 50-300
Previous vascular
surgery or angioplasty,
cardiac infarction within 6 mhs,
severe neuropathy, rest
pain or gangrene,
psychiatric illness, other
reasons making follow-up
difficult, cardiac
or pulmonary impairment,
arthritis limiting exercise,
inability to perform
constant on test occasions
Start antiplatelet
therapy and statins
Zwierska39 37 vs 33 12 mhs stable Critical ischemia,
revascularisation <1 year,
cardiac or pulmonary
impairment, arthritis
limiting exercise
Long term
medication continued
Lee26y 33 vs 37 - - -
Willigendael28 8 vs 8 Eligible for conservative
treatment, ABIrest< 0.9, AWD
500 meters
Physical activity limiting
cardiovascular and
kinesalgia diseases
-
Tsai35 32 vs 32 Fontaine II, ABIrest< 0.95,
ABIex< 0.75,
Living independently
Rest pain, unstable symptoms,
exercise limited by leg pain
of nonvascular origin,
surgery related to PAOD or
myocardial
infarction within 3 months
-
Gelin34 73 vs 76 6 mhs stable, ABI< 0.6
Post-ischemic calf
blood flow; <25 ml/min/100 g
History contraindicating
surgery and/or limiting
evaluation on treadmill
-
Gardner33 31 vs 30 Non smoking,
Fontaine II patients,
older then 60 years,
ABIrest< 0.97,
positive Rose questionnaire
Fontaine I and III, other
significant medical conditions,
exercise limited by other
factors, poorly
controlled diabetes, other
active major medical problems
Continued
Savage37 11 vs 10 >50 years, Grade I or Category
1, 2, or 3z
Unstable cardiopulmonary
disease, severe
arthritis, tobacco
use, weight >40 kg above
ideal, renal insufficiency,
Beta-blocking, Pentoxifylline
or Cilostazol within 8 weeks,
functioning bypass, severe
cognitive impairment
Patients taking
Beta-blocking,
Pentoxifylline,
Cilostazol were
excluded
Regensteiner32 10 vs 10 Disabling, 3 mhs stable
ABIrest< 0.94, ABIex< 0.73
Rest pain or ischemic lesions,
unable to walk on treadmill, cardiac
or pulmonary impairment, arthritis,
diabetes, previous vascular surgery
or angioplasty <1 year
Continued
Patterson36 30 vs 30 50e75 years old,
duration >3 mhs
ABIrest< 0.90, ABIex< 0.75
Rest pain or tissue loss,
exercise limitations because
of co morbid illness, myocardial
ischemia on stress test
-
Hiatt31 10 vs 10 Disabling, 3 mhs stable,
ABIrest< 0.94, ABIex< 0.73
Rest pain or tissue loss,
exercise limitations because
of co morbid illness, diabetes,
previous vascular surgery
or angioplasty <1 year
Continued, dosage
not changed
Eur J Vasc Endovasc Surg Vol 34, July 2007
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Study N *
Randomized
Int vs Cont
Inclusion Exclusion Medication
Jansen41y 24 vs 24 Fontaine II and angiographic
findings
- -
Mannarino30 10 vs 10 Fontaine II, ABI< 0.8 and
angiographic findings
At least 2 years, 3 mhs stable
PWD< 300 meters
Previous vascular
surgery or angioplasty
within 6 mhs, cardiac
or pulmonary impairment,
recent cardiac infarction or
stroke, kidney-, liver-, major
metabolic-, infectious-, malignant
diseases, peptic ulcer
Start antiplatelet
therapy.
Other rheologically,
anticoagulant, or
vasoactive
agents suspended
Hiatt29 14 vs 11 Disabling, 3 mhs stable,
ABIrest< 0.95, A/ABIex< 0.85
Rest pain or tissue loss,
resting ankle pressure <50 mmHg,
exercise limitations because of
co morbid illness, diabetes,
previous vascular surgery
or angioplasty <1 year,
Beta-blocking or Pentoxifylline.
Continued
O: yes; -: no, not (adequate) reported; * including patients that withdrawn their informed consent after randomisation before the interven-
tion.; y Only abstract available; z according to the Society for Vascular Surgery/International Society for Cardiovascular Surgery’s; Con:
Control group; Int: Intervention group; ABIrest: ankle/brachial index at rest; ABIex: ankle/brachial index after exercise; AWD: Absolute
Walking Distance; PWD: Pain Free Walking Distance; mhs: months; PAOD: peripheral arterial occlusive disease.based on economic and logistic factors, rather than on
scientific data.
Our systematic review and meta-analysis indicate
that supervised exercise therapy increases the PWD
and AWD in patients with intermittent claudication.
Whether supervision has additional value over simple
exercise instructions remains a matter of debate. In the
studies comparing supervised to unsupervised exer-
cise therapy, both PWD and AWD were increased;
143.81 meters (95% CI; 5.81-281.81) and 250.40 meters
(95% CI; 192.35-308.45) respectively. One would ex-
pect that the differences between supervised exerciseand standard care would be more pronounced. How-
ever this was not seen in the pooled result of the
studies comparing supervised exercise to standard
care; the WMD in PWD and AWD was 81.29 meters
(95% CI; 35.45-127.14) and 155.79 meters (95% CI;
80.84-230.74), respectively. Most of the included stud-
ies applied an exercise regimen of 2-3 times a week.
The optimal intensity of training is not clear although
it has been suggested that patients exercise until near
maximal pain. Interestingly, in a recent study no dif-
ferences were found between patients training at
40% or 80% of their maximal intensity.14 In addition,Table 2. Quality assessment of the included studies in the systematic review
Publication Randomisation Consecutive
series
Concealment
of allocation
Blinding
data-
assessors
Intention
to treat
Adequate
follow-up
Similar
groups
at
baseline
Similar
treatment
apart from
intervention
Losses to
follow-up
Mika38 O - - O - O O O O
Kakkos27 O - O - O O O -y O
Zwierska39 O - - - O O O O O
Lee26* O - - - - O - - -
Willigendael28 O - - - - O O O O
Tsai35 O - - - O O O O -z
Gelin34 O - - - O O O -y O
Gardner33 O - - - O O O O O
Savage37 O - - - - O O O -
Regensteiner32 O O - - O O O O O
Patterson36 O - - - - O O O O
Hiatt31 O - - - - O O -y O
Jansen41* O - - - - O - - -
Mannarino30 O - - - - O O -y -
Hiatt29 O - - - - O O - O
O: yes; -: no or not (adequately) reported; y Intervention group received additional exercise instructions for at home; z Numbers given, not
reasons; * Only abstract available.Eur J Vasc Endovasc Surg Vol 34, July 2007
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Author Intervention Control
Supervised exercise vs standard care
Mika38 12w, 3x/w no intervention
Zwierska27 24w, 2x/w, 40 min, crank exercise encouragement
Lee26 12w, conventional medical treatment
Tsai35 12w, 3x/w, 30 min no intervention
Gelin34 26w, 3x/w, 30 min, walks no intervention
Gardner33 26w, 3x/w, 60 min, 2 30 min no intervention
Hiatt31 13w, 3x/w, 60 min, 2 30 min no other activity than usual
Jansen41 104w, 2x/w conventional medical treatment
Mannarino30 26w, 2x/w, daily walk Dipyridamole 3 75 mg, aspirin 330 mg
Hiatt29 13w, 3x/w, 60 min, 2 30 min no other activity than usual
Supervised exercise vs exercise instructions
Kakkos27 26w, 3x/w, daily exercise daily 45 min walk
Willigendael28 3w, 3x/w, daily exercise walk 3x/d
Savage37 12w, 3x/w, 12w, 40 min, 3x/w
Regensteiner32 12w, 3x/w, 60 min, 2 30 min 3x/w, 35-50 min
Patterson36 12w, 3x/w, lectures 12w, 20-40 min, 3x/w, lecturesthe optimal duration of and type of exercise therapy
remains uncertain. Most studies reported short-term
effects only, and the maximum duration of exercise
therapy in the included studies was 6 months with
the exception of one study.41
Alternative training therapies have been proposed
including individualized home based training pro-
grammes which are guided by the pain threshold.
These programmes are a compromise between super-
vised physical training and mere advice to get more
exercise. The pain threshold is used to guide the exer-
cise therapy, prescribed at the hospital and performed
at home.42 These programmes have not been evalu-
ated thoroughly.Eur J Vasc Endovasc Surg Vol 34, July 2007Our systematic review has many limitations; the
overall methodological quality of the included studies
was moderate with several sources of bias, limiting the
level of evidence of this systematic review. Only
few studies provided details about the process of ran-
domisation, or used allocation concealment and asses-
sor blinding to minimise bias. In addition, nearly all
studies had a very small sample size. Although meta-
analysis is a powerful tool to identify possible differ-
ences in efficacy of a treatment, it would have been
preferable if the original studies had been adequately
powered to enable the detection of such differences.
The generalisability of the individual single-centre
study results is unclear. In addition, the majority ofTable 4. Results of the included studies in the systematic review
Author Year Age
(yrs)
Male
(%)
Evaluated
patients*
Con vs Int
PWD on entry
meters (SD)
Con vs Int
AWD on entry meters
(SD) Con vs Int
PWD after
intervention meters
(SD) Con vs Int
AWD after
intervention meters
(SD) Con vs Int
Supervised exercise vs standard care
Mika38 2005 61 83 37 vs 41 87 (40) vs 87 (38) - 102 (50) vs 192 (95) -
Zwierska27 2005 69 77 33 vs 37 135 (88) vs 124 (111) 297 (141) vs 337 (132) 123 (83) vs 156 (129) 278 (124) vs 402 (149)
Lee26 2005 68 69 37 vs 33 76 (61) vs 57 (40) 126 (68) vs 105 (61) 109 (87) vs 110 (62) 200 (121) vs 226 (89)
Tsai35 2002 76 83 26 vs 27 155 (139) vs 176 (165) 384 (171) vs 395 (208) 171 (181) vs 331 (144) 405 (203) vs 667 (197)
Gelin34 2001 67 67 76 vs 73 - 272 (153) vs 258 (142) - 261 (131) vs 247 (111)
Gardner33 2001 71 90 28 vs 24 163 (23) vs 172 (26) 379 (48) vs 396 (43) 203 (43) vs 402 (56) 425 (56) vs 702 (57)
Hiatt31 1994 67 100 10 vs 8 203 (123) vs 176 (107) 395 (176) vs 512 (304) 165 (69) vs 357 (229) 398 (144) vs 784 (389)
Jansen41 1991 - - 24 vs 24 89 (9) vs 116 (14) 145 (16) vs 191 (27) 111 (13) vs 196 (26) 171 (25) vs 320 (50)
Mannarino30 1991 63 65 10 vs 10 56 (19) vs 50 (24) 83 (31) vs 88 (32) 72 (23) vs 99 (28) 100 (34) vs 160 (25)
Hiatt29 1990 60 100 9 vs 10 - 320 (107) vs 341 (91) - 379 (155) vs 741 (187)
Supervised exercise vs exercise instructions
Kakkos27 2005 63 90 9 vs 8 67 (14) vs 60 (17) 156 (63) vs 166 (69) 65 (23) vs 92 (30) 151 (31) vs 350 (270)
Willigendael28 2005 63 71 7 vs 7 - 206 (189) vs 193 (109) - 381 (353) vs 684 (687)
Savage37 2001 66 71 10 vs 11 183 (151) vs 241 (188) 532 (264) vs 522 (263) 226 (151) vs 457 (317) 737 (290) vs 833 (376)
Regensteiner32 1997 64 - 10 vs 10 123 (107) vs 107 (69) 331 (192) vs 245 (128) 155 (75) vs 267 (181) 347 (224) vs 581 (240)
Patterson36 1997 69 53 28 vs 27 88 (64) vs 88 (64) 145 (81) vs 145 (81) 187 (107) vs 427 (142) 303 (125) vs 569 (125)
Con: Control group; Int: Intervention group; AWD: Absolute Walking distance; PWD: Pain Free Walking Distance; SD: standard deviation.
* Generally less than the number of randomized patients (see Table 1).
7Exercise Therapy and the Additional Effect of Supervision on Exercise TherapyFig. 1. Weighted mean difference (WMD) of pain free walking distance.data on supervised exercise therapy were obtained
from the same few centers. Furthermore, the included
studies applied various exclusion criteria, such as car-
diac or pulmonary impairment, diabetes, smoking be-
haviour, and even use of antiplatelet drugs. Finally,
few studies described the localisation and severity ofperipheral arterial disease. It is therefore likely that
there was considerable heterogeneity between study
populations, which is reflected by the wide range in
baseline PWD and AWD. The fact that nearly all stud-
ies reported positive results could be an indication of
publication bias. This probably applies particularly toFig. 2. Weighted mean difference (WMD) of maximum walking distance.Eur J Vasc Endovasc Surg Vol 34, July 2007
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control, as in these studies a larger than expected
treatment effect was found. Although we did not sys-
tematically look for unpublished studies, we tried to
include as many studies as possible by contacting
authors when data were lacking, to maximise the
number of studies and patients in our analysis.
We chose to express the primary outcome as the
distance in meters, as we thought this would yield
more information than a relative change in walking
distance. This required calculation of distances when
studies reported walking ability as time until onset
of pain or maximum walking time. In all studies,
the final assessment was done on a treadmill with
varying speed and slope, and sometimes even an in-
cremental speed was used. It is likely that such het-
erogeneous ways of testing imply that walking
distances are not fully comparable. It has been
suggested that the shuttle walking test is a more re-
presentative and better reproducible test to evaluate
intermittent claudication,40 but this test was not
used. A relative change could be more important,
since doubling of walking distance could benefit a per-
son with a very limited walking distance, although
this might be better expressed through quality of life
evaluations. Unfortunately, quality of life was re-
ported in only a few studies.
It is possible that the results can be explained par-
tially by the Hawthorne effect. The Hawthorne effect
describes the effect that the awareness of being under
observation can alter the way a patient behaves or
positively influence the outcome of a study as the
control patients in some of the studies showed an
increase in walking distance at the end of the study
period.43
So, after 15 randomised trials including only 761
patients, and 8 systematic reviews on this topic, we
know that exercise therapy increases the PWD and
AWD in patients with intermittent claudication. We
also know that supervised exercise therapy increases
the PWD and AWD more than standard care. How-
ever, the additional value of supervision over unsu-
pervised exercise regimens needs to be clarified. No
optimal exercise regimen could be extracted from
our analysis. Thus, more multi-centre prospective
randomised trials are needed to confirm the prelimi-
nary results of supervised exercise training in patients
with intermittent claudication.
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